#biotech

A cancer treatment known as CAR T-cell therapy is being repurposed to combat autoimmune diseases like multiple sclerosis. Early trials are exploring how this technology, which reprograms a patient's own cells, can be used to treat conditions where the immune system mistakenly attacks the body.